RELAPSED B-CELL NHL

Clinical trials for RELAPSED B-CELL NHL explained in plain language.

Never miss a new study

Get alerted when new RELAPSED B-CELL NHL trials appear

Sign up with your email to follow new studies for RELAPSED B-CELL NHL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for hard-to-treat lymphoma? early trial begins for experimental drug

Disease control Ongoing

This early-phase study tests a new drug called JNJ-88998377 in about 58 people with B-cell non-Hodgkin's lymphoma that has returned or not responded to prior treatments. The main goal is to check the drug's safety and find the best dose for future studies. Participants will be cl…

Matched conditions: RELAPSED B-CELL NHL

Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control

Last updated May 17, 2026 02:08 UTC

RELAPSED B-CELL NHL

Get alerted when new RELAPSED B-CELL NHL trials appear

New hope for hard-to-treat lymphoma? early trial begins for experimental drug